{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:34:55Z","timestamp":1790040895956,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jacr.2012.10.021","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T18:59:28Z","timestamp":1359658768000},"page":"83-92","source":"Crossref","is-referenced-by-count":58,"title":["ACR Appropriateness Criteria Prostate Cancer\u2014Pretreatment Detection, Staging, and Surveillance"],"prefix":"10.1016","volume":"10","author":[{"given":"Steven C.","family":"Eberhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Casalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Leyendecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytekin","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick M.","family":"Remer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2012.10.021_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jacr.2012.10.021_bib2","series-title":"Prostate-specific antigen best practice statement: 2009 update","year":"2009"},{"key":"10.1016\/j.jacr.2012.10.021_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.6004\/jnccn.2010.0016","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer early detection","volume":"8","author":"Kawachi","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jacr.2012.10.021_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.crad.2007.10.020","article-title":"Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours","volume":"63","author":"Cirillo","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1148\/radiol.10101251","article-title":"Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding\u2014multiparametric MR imaging for detection and biopsy planning","volume":"259","author":"Franiel","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.juro.2009.10.022","article-title":"Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen","volume":"183","author":"Hambrock","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00345-011-0675-2","article-title":"MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy","volume":"30","author":"Roethke","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2214\/AJR.09.7196","article-title":"A clinically relevant approach to imaging prostate cancer: review","volume":"196","author":"Verma","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib9","series-title":"AJCC cancer staging manual","year":"2010"},{"key":"10.1016\/j.jacr.2012.10.021_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0045(20000915)45:1<19::AID-PROS3>3.0.CO;2-M","article-title":"Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer","volume":"45","author":"Candas","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.jacr.2012.10.021_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib12","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","article-title":"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005","volume":"69","author":"Makarov","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(05)00327-7","article-title":"Pathological characteristics of prostate cancer detected through prostate specific antigen based screening","volume":"175","author":"Loeb","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib15","series-title":"Guideline for management of clinically localized prostate cancer: 2007 update","year":"2007"},{"key":"10.1016\/j.jacr.2012.10.021_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-5347(05)65392-X","article-title":"Preoperative serum prostate specific antigen levels between 2 and 22 ng.\/ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng.\/ml","volume":"167","author":"Stamey","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib17","series-title":"Prostate-specific antigen-based screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force","author":"Lin","year":"2011"},{"key":"10.1016\/j.jacr.2012.10.021_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/01.ju.0000049200.30192.d1","article-title":"Pretreatment predictors of time to cancer specific death after prostate specific antigen failure","volume":"169","author":"D'Amico","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0090-4295(02)02425-1","article-title":"Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate","volume":"61","author":"Roach","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D'Amico","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1464-410X.2003.04669.x","article-title":"Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort","volume":"93","author":"el-Geneidy","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/jama.284.11.1399","article-title":"Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection","volume":"284","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2012.10.021_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/01.ju.0000139993.51181.5d","article-title":"The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?","volume":"172","author":"Stamey","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-5347(02)80309-3","article-title":"Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging 1974","volume":"167","author":"Gleason","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0090-4295(01)01233-X","article-title":"Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer","volume":"58","author":"Kattan","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2012.01.047","article-title":"Three-tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers","volume":"62","author":"Hoeks","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/end.2010.0425","article-title":"Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease","volume":"25","author":"Katz","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.jacr.2012.10.021_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0090-4295(94)80134-7","article-title":"Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer","volume":"44","author":"Sands","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.juro.2008.05.044","article-title":"External validation of the updated Partin tables in a cohort of North American men","volume":"180","author":"Karakiewicz","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib31","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/S0022-5347(05)66349-5","article-title":"A catalog of prostate cancer nomograms","volume":"165","author":"Ross","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.juro.2009.08.143","article-title":"Validation of the Partin nomogram for prostate cancer in a national sample","volume":"183","author":"Yu","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ncpuro0972","article-title":"Predictive models and prostate cancer","volume":"5","author":"Karakiewicz","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib34","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2002.03.061","article-title":"Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer","volume":"20","author":"D'Amico","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0360-3016(00)00577-0","article-title":"Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials","volume":"47","author":"Roach","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacr.2012.10.021_bib36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.2000.18.6.1164","article-title":"Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer","volume":"18","author":"D'Amico","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/djj190","article-title":"Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"98","author":"Stephenson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jacr.2012.10.021_bib38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2007.08.021","article-title":"Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance","volume":"70","author":"Williams","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacr.2012.10.021_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.1017","article-title":"Clinical staging of prostate cancer: reproducibility and clarification of issues","volume":"96","author":"Campbell","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jacr.2012.10.021_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/ajr.155.5.2120928","article-title":"Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle","volume":"155","author":"Hamper","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1148\/radiology.178.3.1994420","article-title":"Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation","volume":"178","author":"Hamper","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)37720-0","article-title":"Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging","volume":"146","author":"McSherry","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199009063231001","article-title":"Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer","volume":"323","author":"Rifkin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2214\/ajr.175.4.1751161","article-title":"Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings","volume":"175","author":"Cornud","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0302-2838(03)00204-5","article-title":"Value of power Doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer","volume":"44","author":"Sauvain","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pros.10145","article-title":"Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens","volume":"53","author":"Sedelaar","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.jacr.2012.10.021_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.juro.2007.03.107","article-title":"Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score","volume":"178","author":"Mitterberger","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1464-410X.2007.06845.x","article-title":"The value of three-dimensional transrectal ultrasonography in staging prostate cancer","volume":"100","author":"Mitterberger","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1148\/radiology.204.2.9240538","article-title":"Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging","volume":"204","author":"Getty","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiology.190.2.8284376","article-title":"MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens","volume":"190","author":"Quinn","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiology.178.3.1994421","article-title":"Prostate cancer: local staging with endorectal surface coil MR imaging","volume":"178","author":"Schnall","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.192.1.8208963","article-title":"Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques","volume":"192","author":"Tempany","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1148\/radiol.2381041832","article-title":"Prostate cancer: local staging at 3-T endorectal MR imaging\u2014early experience","volume":"238","author":"Futterer","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00004424-200411000-00005","article-title":"Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate","volume":"39","author":"Futterer","year":"2004","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib55","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2214\/AJR.04.1584","article-title":"MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging","volume":"185","author":"Beyersdorff","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.pcan.4500767","article-title":"Magnetic resonance imaging in prostate cancer","volume":"7","author":"Heenan","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jacr.2012.10.021_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2214\/ajr.166.4.8610561","article-title":"Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology","volume":"166","author":"Jager","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02841850902889846","article-title":"Accuracy of 3-tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables","volume":"50","author":"Augustin","year":"2009","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1148\/radiol.2451061502","article-title":"Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging\u2014initial results","volume":"245","author":"Bloch","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1148\/radiol.2321031254","article-title":"Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging","volume":"232","author":"Mullerad","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib61","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.20319","article-title":"The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy","volume":"100","author":"Hricak","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2012.10.021_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1464-410x.2001.00018.x","article-title":"Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer","volume":"87","author":"May","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.202.1.8988214","article-title":"Staging prostate cancer with MR imaging: a combined radiologist-computer system","volume":"202","author":"Seltzer","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib64","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1148\/radiol.2383050657","article-title":"Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis","volume":"238","author":"Sala","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-5347(05)67297-7","article-title":"Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer","volume":"164","author":"D'Amico","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib66","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2003.10.035","article-title":"Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer","volume":"59","author":"Nguyen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacr.2012.10.021_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/radiol.2321031086","article-title":"Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension","volume":"232","author":"Wang","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib68","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.198.3.8628874","article-title":"Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution","volume":"198","author":"Kurhanewicz","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib69","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/01.ju.0000094958.23276.c4","article-title":"Magnetic resonance imaging and spectroscopic imaging of prostate cancer","volume":"170","author":"Coakley","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1148\/radiol.2343040363","article-title":"Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy","volume":"234","author":"Zakian","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib71","doi-asserted-by":"crossref","first-page":"500","DOI":"10.47102\/annals-acadmedsg.V32N4p500","article-title":"MR imaging and MR spectroscopy of adenocarcinoma of the prostate","volume":"32","author":"Kwek","year":"2003","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jacr.2012.10.021_bib72","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.juro.2010.07.037","article-title":"An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy","volume":"184","author":"Zakian","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1148\/radiol.2511080409","article-title":"Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy\u2014results of ACRIN prospective multi-institutional clinicopathologic study","volume":"251","author":"Weinreb","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib74","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiology.203.3.9169683","article-title":"Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results","volume":"203","author":"Jager","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/crad.1999.0327","article-title":"Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA","volume":"55","author":"Padhani","year":"2000","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiol.2372041724","article-title":"Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers","volume":"237","author":"Futterer","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1148\/radiol.2412051866","article-title":"Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging","volume":"241","author":"Futterer","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib78","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.ejrad.2011.01.107","article-title":"Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology","volume":"81","author":"Isebaert","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2214\/AJR.07.2211","article-title":"Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer","volume":"189","author":"Haider","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib80","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1148\/radiol.11102066","article-title":"Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness","volume":"259","author":"Vargas","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib81","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1464-410X.2010.09808.x","article-title":"Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging","volume":"107","author":"Delongchamps","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1148\/radiol.11091822","article-title":"Prostate cancer: multiparametric MR imaging for detection, localization, and staging","volume":"261","author":"Hoeks","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib83","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1148\/radiol.10091343","article-title":"Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features","volume":"255","author":"Langer","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib84","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.juro.2010.10.076","article-title":"D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging","volume":"185","author":"Rastinehad","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1148\/radiology.162.2.3797645","article-title":"Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging","volume":"162","author":"Hricak","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2012.10.021_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2214\/ajr.149.2.315","article-title":"The accuracy of CT in the staging of carcinoma of the prostate","volume":"149","author":"Platt","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2012.10.021_bib87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0090-4295(92)90386-B","article-title":"Preoperative assessment of prostatic carcinoma by computerized tomography","volume":"40","author":"Engeler","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib88","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib89","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)67710-5","article-title":"The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis","volume":"163","author":"Albertsen","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib90","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1586::AID-CNCR21>3.0.CO;2-F","article-title":"Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients","volume":"85","author":"Polascik","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2012.10.021_bib91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1078-1439(02)00253-3","article-title":"Histologic confirmation of lesions identified by Prostascint scan following definitive treatment","volume":"21","author":"Bermejo","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/suro.2002.36250","article-title":"The utility of monoclonal antibodies in the imaging of prostate cancer","volume":"20","author":"Yao","year":"2002","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib93","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/pros.10319","article-title":"Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene","volume":"58","author":"O'Keefe","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.jacr.2012.10.021_bib94","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0094-0143(21)00923-X","article-title":"Using PSA to eliminate the staging radionuclide bone scan","volume":"20","author":"Oesterling","year":"1993","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.jacr.2012.10.021_bib95","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000421-199410000-00016","article-title":"Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?","volume":"17","author":"Vijayakumar","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib96","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/cncr.10340","article-title":"Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma?","volume":"94","author":"Kosuda","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2012.10.021_bib97","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1464-410X.2003.04480.x","article-title":"Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital","volume":"92","author":"O'Sullivan","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1464-410x.2001.02275.x","article-title":"Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase","volume":"88","author":"Wymenga","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2012.10.021_bib99","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/01.ju.0000123981.03084.06","article-title":"Baseline staging of newly diagnosed prostate cancer: a summary of the literature","volume":"171","author":"Abuzallouf","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib100","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib101","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12149-010-0393-7","article-title":"A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor","volume":"24","author":"Tateishi","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib102","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.rcl.2004.08.007","article-title":"PET in the management of urologic malignancies","volume":"42","author":"Kumar","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jacr.2012.10.021_bib103","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/01.blo.0000093051.96273.7c","article-title":"Diagnosis of occult bone metastases: positron emission tomography","author":"Peterson","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jacr.2012.10.021_bib104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00345-004-0418-8","article-title":"PET and prostate cancer","volume":"22","author":"Sanz","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12149-010-0424-4","article-title":"The potential of FDG-PET\/CT for detecting prostate cancer in patients with an elevated serum PSA level","volume":"25","author":"Minamimoto","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(00)00896-7","article-title":"Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer","volume":"57","author":"Liu","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2012.10.021_bib107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.ju.0000148326.71981.44","article-title":"Detection of prostate cancer with 11C-methionine positron emission tomography","volume":"173","author":"Toth","year":"2005","journal-title":"J Urol"},{"issue":"suppl 1","key":"10.1016\/j.jacr.2012.10.021_bib108","first-page":"172S","article-title":"(68)Ga-labeled peptides in tumor imaging","volume":"46","author":"Maecke","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib109","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-156-8-201204170-00009","article-title":"Active surveillance in men with localized prostate cancer: a systematic review","volume":"156","author":"Dahabreh","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2012.10.021_bib110","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1200\/JCO.2011.34.9738","article-title":"Active surveillance for prostate cancer: progress and promise","volume":"29","author":"Cooperberg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacr.2012.10.021_bib111","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.juro.2008.07.051","article-title":"Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance","volume":"180","author":"Berglund","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RLI.0b013e31823ea1f0","article-title":"Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score <\/=3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series","volume":"47","author":"Somford","year":"2012","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jacr.2012.10.021_bib113","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.juro.2011.11.112","article-title":"Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study","volume":"187","author":"Margel","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.jacr.2012.10.021_bib114","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.2472070770","article-title":"Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?","volume":"247","author":"Cabrera","year":"2008","journal-title":"Radiology"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144012006692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144012006692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T10:16:44Z","timestamp":1714904204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144012006692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1546144012006692"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2012.10.021","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}